Commonly Used Surfactant, Tween 80, Improves Absorption of P-Glycoprotein Substrate, Digoxin, in Rats |
Zhang, Hongjian
(Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Pharmaceutical Research Institute)
Yao, Ming (Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Pharmaceutical Research Institute) Morrison, Richard-A. (Schering-Plough Research Institute) Chong, Sae-Ho (Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Pharmaceutical Research Institute) |
1 | Cornaire, G., Woodley, J. F., Saivin, S., Legendre, J.Y., Decourt, S., Cloarec, A., and Houin, G., Effect of polyoxyl 35 castor oil and Polysorbate 80 on the intestinal absorption of digoxin in vitro. Arzneimittel-forschung., 50, 576-579 (2000) PUBMED |
2 | Hedman, A., Angelin, B., Arvidsson, A., Dahlqvist, R., and Nilsson, B.. Interactions in the renal and biliary elimination of digoxin: stereoselective difference between quinine and quinidine. Clin. Pharmacol. Ther., 47, 20-26 (1990) DOI PUBMED ScienceOn |
3 | Hinderling, P. H. and Hartmann, D., Pharmacokinetics of digoxin and main metabolites/ derivatives in healthy humans. Ther. Drug Monit., 13, 381-401 (1991) DOI PUBMED ScienceOn |
4 | Hugger, E. D., Novak, B. L., Burton, P. S., Audus, K. L., and Borchardt, R. T., A comparison of commonly used polyehtoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro. J. Pharm. Sci., 91, 1991-2002 (2002) DOI ScienceOn |
5 | Litman, T., Druley, T. E., Stein, W. D., and Bates, S. E., From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell. Mol. Life Sci. 58, 931-959 (2001) DOI ScienceOn |
6 | Malingre, M M., Schellens, J. H., Van Tellingen, O., Ouwehand, M., Bardelmeijer, H. A., Rosing, H., Koopman, F. J., Schot, M. E., Ten Bokkel Huinink, W. W., and Beijnen, J. H., The cosolvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients. Br. J. Cancer, 85, 1472-1477 (2001) DOI ScienceOn |
7 | Stephens, R. H., O'Neill, C. A., Warhurst, A., Carlson, G. L., Rowland, M., and Warhurst, G., Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia. J. Pharmacol. Exp. Ther., 296, 584-591 (2001) PUBMED |
8 | Verschraagen, M., Koks, C. H., Schellens, J. H., and Beijnen, J. H., P-glycoprotein system as a determinant of drug interactions: the case of digoxin-verapamil. Pharmacol. Res., 40, 301-306 (1999) DOI ScienceOn |
9 | Yao, M., Zhang, H., Chong, S., Zhu, M., and Morrison, R. A., A rapid and sensitive LC/MS/MS assay for quantitative determination of digoxin in rat plasma. J. Pharmaceu. Biomed. Anal., 32, 1189-1197 (2003) DOI ScienceOn |
10 | Silverman, J. A., Multidrug-resistance transporters. Pharm. Biotechnol., 12, 353-86 (1999) PUBMED |
11 | Tanigawara, Y., Role of P-glycoprotein in drug disposition. Ther. Drug Monit., 22, 137-140 (2000) DOI PUBMED ScienceOn |
12 | Salphati, L. and Benet, L. Z., Metabolism of digoxin and digoxigenin digitoxosides in rat liver microsomes: involvement of cytochrome P4503A. Xenobiotica, 29, 171-85 (1999) DOI PUBMED ScienceOn |
13 | Troutman, M. D., Luo, G., Gan, L. S., and Thakker, D. R., The role of P-glycoprotein in drug disposition: significance to drug development. In Rodrigues, A. D. (ed.). Drug-drug interactions. Marcel Dekker, New York. pp. 295-357 (2001) |
14 | Fromm, M. F., Kim, R. B., Stein, C. M., Wilkinson, G. R., and Roden, D. M., Inhibition of P-glycoprotein-mediated drug transport: A unifying mechanism to explain the interaction between digoxin and quinidine. Circulation, 99, 552-557 (1999) DOI PUBMED ScienceOn |
15 | Gottesman, M. M. and Pastan, I., Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem., 62, 385-427 (1993) DOI ScienceOn |
16 | Nerurkar, M. M., Ho, N. F., Burton, P. S., Vidmar, T. J., and Borchardt, R. T., Mechanistic roles of neutral surfactants on concurrent polarized and passive membrane transport a model peptide in Caco-2 cells. J. Pharm. Sci., 86, 813-821 (1997) DOI ScienceOn |
17 | Salphati, L. and Benet, L. Z., Effects of ketoconazole on digoxin absorption and disposition in rat. Pharmacology, 56, 308-313 (1998) DOI ScienceOn |
18 | Knutsen, T., Mickley, L. A., Ried, T., Green, E. D., du Manoir, S., Schrock, E., Macville, M., Ning, Y., Robey, R., Polymeropoulos, M., Torres, R., and Fojo, T., Cytogenetic and molecular characterization of random chromosomal rearrangements activating the drug resistance gene, MDR1/P-glycoprotein, in drug-selected cell lines and patients with drug refractory ALL. Genes Chromosomes Cancer, 23, 44-54 (1998) DOI ScienceOn |
19 | van Zuylen, L., Verweij, J., and Sparreboom, A., Role of formulation vehicles in taxane pharmacology. Invest. New Drugs, 19,125-141 (2001) DOI ScienceOn |
20 | Song, S., Suzuki, H., Kawai, R., and Sugiyama, Y., Effect of PSC 833, a P-glycoprotein modulator, on the disposition of vincristine and digoxin in rats. Drug Metab. Disp., 27, 689-694 (1999) |
21 | Iisalo, E., Clinical pharmacokinetics of digoxin. Clin. Pharmacokinet., 2, 1-16 (1977) DOI PUBMED ScienceOn |
22 | Yamazaki, M., Neway, W. E., Ohe, T., Chen, I., Rowe, J. F., Hochman, J. H., Chiba, M., and Lin, J. H., In vitro substrate identification studies for p-glycoprotein-mediated transport: species difference and predictability of in vivo results. J. Pharmacol. Exp. Ther., 296, 723-735 (2001) PUBMED |
23 | Batrakova, E. V., Han, H. Y., Alakhov, V. Y., Miller, D. W., and Kabanov, A. V., Effects of pluronic block copolymers on drug absorption in Caco-2 cell monolayers. Pharm. Res., 15, 850-855 (1998) DOI ScienceOn |
24 | Borst, P., Evers, R., Kool, M., and Wijnholds, J., The multidrug resistance protein family. Biophys. Acta, 1461, 347-357 (1999) DOI ScienceOn |